48 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Apoetm1Bres/Apoetm1Bres Plautm1Mlg/Plautm1Mlg involves: 129 * C57BL/6	aortic elastic tissue lesions	J:44387
	decreased susceptibility to atherosclerosis	J:44387
Apoetm1Unc/Apoetm1Unc Tg(MSR1-Plau)1Ddi/0 involves: 129P2/OlaHsd * C57BL/6 * SJL	abnormal artery morphology	J:102208
	abnormal heart morphology	J:101486
	artery occlusion	J:101486, J:102208
	enlarged heart	J:101486
	heart inflammation	J:101486
	increased susceptibility to atherosclerosis	J:102208
	increased susceptibility to induced morbidity/mortality	J:102208
Ddit3tm1.1Irt/Ddit3tm1.1Irt Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Mup3-Plau)350-2Eps/? involves: C57BL/6 * DBA	increased hepatocellular carcinoma incidence	J:233146
Plattm1Mlg/Plattm1Mlg Plautm1Mlg/Plautm1Mlg involves: 129S2/SvPas * C57BL/6	abnormal eyelid morphology	J:17427
	abnormal facial skin morphology	J:17427
	abnormal outer ear skin morphology	J:17427
	abnormal thrombosis	J:17427
	cachexia	J:17427
	cellular necrosis	J:17427
	decreased body size	J:17427
	decreased body weight	J:17427
	decreased litter size	J:17427
	postnatal growth retardation	J:17427
	premature death	J:17427
	rectal prolapse	J:17427
	reduced fertility	J:17427
	reduced thrombolysis	J:17427
	respiratory distress	J:17427
Plautm1Mlg/Plautm1Mlg Tg(RIP1-Tag)2Dh/0 involves: C57BL/6	normal cardiovascular system phenotype	J:65019
	increased carcinoma incidence	J:65019
Plautm1Mlg/Plautm1Mlg Thbdtm2Rdr/Thbdtm2Rdr involves: 129S2/SvPas	embryonic lethality	J:47676
Plaurtm1Jld/Plaurtm1Jld Tg(MSR1-Plau)1Ddi/0 B6.Cg-Plaurtm1Jld Tg(MSR1-Plau)1Ddi	cardiac fibrosis	J:113474
	heart inflammation	J:113474
Plgtm1Jld/Plg+ Tg(MSR1-Plau)1Ddi/0 B6.Cg-Plgtm1Jld Tg(MSR1-Plau)1Ddi	abnormal heart morphology	J:113474
Tg(MSR1-Plau)1Ddi/0 involves: C57BL/6 * SJL	cardiac fibrosis	J:101486
	enlarged heart	J:101486
	heart inflammation	J:101486
Tg(Mup3-Plau)350-2Eps/? C57BL/6-Tg(Mup3-Plau)350-2Eps	abnormal circulating alanine transaminase level	J:233146
	abnormal endoplasmic reticulum morphology	J:233146
	abnormal hepatocyte morphology	J:233146
	hepatic necrosis	J:233146
	hepatic steatosis	J:233146
	increased hepatocellular carcinoma incidence	J:233146
	increased hepatocyte apoptosis	J:233146
	increased interleukin-1 beta secretion	J:233146
	increased liver adenoma incidence	J:233146
	increased liver cholesterol level	J:233146
	increased liver free fatty acids level	J:233146
	increased liver triglyceride level	J:233146
	increased liver tumor incidence	J:233146
	increased tumor necrosis factor secretion	J:233146
	liver fibrosis	J:233146
	liver hyperplasia	J:233146
	liver inflammation	J:233146
Tg(Mup3-Plau)350-2Eps/0 involves: C57BL/6	normal cardiovascular system phenotype	J:66132
	increased circulating alanine transaminase level	J:66132
	increased liver tumor incidence	J:66132
	pale liver	J:66132
Tg(Mup3-Plau)350-2Eps/0 involves: C57BL/6 * FVB/N	subcutaneous edema	J:66132